FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2601256495> ?p ?o ?g. }

• W2601256495 endingPage "599" @default.
• W2601256495 startingPage "589" @default.
• W2601256495 abstract "The number of new psychoactive substances (NPS) introduced through the online recreational drugs market increases continuously. This report from the Swedish STRIDA project describes analytically confirmed intoxications involving the novel fentanyl analogs acrylfentanyl, 4-chloroisobutyrfentanyl (4Cl-iBF), 4-fluoroisobutyrfentanyl (4F-iBF), and tetrahydrofuranfentanyl (THF-F), and cyclopentylfentanyl in a drug product.Patients with suspected NPS exposure presenting in emergency departments (ED) or intensive care units (ICU) in Sweden and requiring hospital care are invited to the STRIDA project. NPS analysis of serum and urine samples was performed by multi-component liquid chromatography-mass spectrometry. Data on clinical features were retrieved from telephone consultations with the Swedish Poisons Information Centre and from medical records.Between April and October 2016, eleven intoxications involving acrylfentanyl (8 cases), acrylfentanyl together with 4Cl-iBF (1), 4F-iBF (1), and THF-F (1) were analytically confirmed. Patients were aged 19-51 (median 28) years and 91% were men. Six (55%) were monitored at the ED, and five admitted to the ICU. Typical clinical features were decreased consciousness, respiratory depression, and miosis. In 8 cases, the antidote naloxone was administered to counter the opioid effects. The 4F-iBF positive patient eventually died of brain edema. The serum acrylfentanyl concentration (n = 8) ranged 0.5-2.1 (median 0.9) ng/mL, and in urine (n = 9) 0.2-10.5 (mean 4.6, median 5.2) μg/mmol creatinine. For 4Cl-iBF, 4F-iBF, and THF-F (n = 1 each), higher serum (5-45 ng/mL) and urine (11-136 μg/mmol creatinine) concentrations were found. Other NPS (e.g., flunitrazolam) and/or classical drugs were detected in five cases. In early 2016, nasal sprays with a claimed content of acrylfentanyl brought to hospital by patients or obtained by test purchase were demonstrated to instead contain fentanyl.Potentially life-threatening opioid toxicity was seen in 11 acute intoxications involving the fentanyl analogs acrylfentanyl, 4Cl-iBF, 4F-iBF, and THF-F, which are available through open Internet trading. All patients were supported with acute and intensive hospital care, and naloxone was effective to reverse the opioid symptoms. One patient died of brain edema." @default.
• W2601256495 created "2017-04-07" @default.
• W2601256495 creator A5002344568 @default.
• W2601256495 creator A5010941814 @default.
• W2601256495 creator A5067339649 @default.
• W2601256495 creator A5075615465 @default.
• W2601256495 date "2017-03-28" @default.
• W2601256495 modified "2023-10-14" @default.
• W2601256495 title "Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project" @default.
• W2601256495 cites W1677982525 @default.
• W2601256495 cites W1907057520 @default.
• W2601256495 cites W1964183466 @default.
• W2601256495 cites W2002121254 @default.
• W2601256495 cites W2003089312 @default.
• W2601256495 cites W2014026261 @default.
• W2601256495 cites W2016855037 @default.
• W2601256495 cites W2028152704 @default.
• W2601256495 cites W2038584335 @default.
• W2601256495 cites W2038997199 @default.
• W2601256495 cites W2060476415 @default.
• W2601256495 cites W2063923754 @default.
• W2601256495 cites W2064048795 @default.
• W2601256495 cites W2064437704 @default.
• W2601256495 cites W2080159654 @default.
• W2601256495 cites W2094038108 @default.
• W2601256495 cites W2100962265 @default.
• W2601256495 cites W2101238223 @default.
• W2601256495 cites W2104134427 @default.
• W2601256495 cites W2118425345 @default.
• W2601256495 cites W2128270192 @default.
• W2601256495 cites W2149730050 @default.
• W2601256495 cites W2153864222 @default.
• W2601256495 cites W2158718923 @default.
• W2601256495 cites W2252577233 @default.
• W2601256495 cites W2298818449 @default.
• W2601256495 cites W2469735785 @default.
• W2601256495 cites W2492685836 @default.
• W2601256495 cites W2514653748 @default.
• W2601256495 cites W2514932497 @default.
• W2601256495 cites W2520161253 @default.
• W2601256495 cites W2916623554 @default.
• W2601256495 doi "https://doi.org/10.1080/15563650.2017.1303141" @default.
• W2601256495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28349714" @default.
• W2601256495 hasPublicationYear "2017" @default.
• W2601256495 type Work @default.
• W2601256495 sameAs 2601256495 @default.
• W2601256495 citedByCount "80" @default.
• W2601256495 countsByYear W26012564952017 @default.
• W2601256495 countsByYear W26012564952018 @default.
• W2601256495 countsByYear W26012564952019 @default.
• W2601256495 countsByYear W26012564952020 @default.
• W2601256495 countsByYear W26012564952021 @default.
• W2601256495 countsByYear W26012564952022 @default.
• W2601256495 countsByYear W26012564952023 @default.
• W2601256495 crossrefType "journal-article" @default.
• W2601256495 hasAuthorship W2601256495A5002344568 @default.
• W2601256495 hasAuthorship W2601256495A5010941814 @default.
• W2601256495 hasAuthorship W2601256495A5067339649 @default.
• W2601256495 hasAuthorship W2601256495A5075615465 @default.
• W2601256495 hasConcept C118552586 @default.
• W2601256495 hasConcept C126322002 @default.
• W2601256495 hasConcept C139719470 @default.
• W2601256495 hasConcept C162324750 @default.
• W2601256495 hasConcept C170493617 @default.
• W2601256495 hasConcept C177713679 @default.
• W2601256495 hasConcept C194828623 @default.
• W2601256495 hasConcept C2776867660 @default.
• W2601256495 hasConcept C2778750930 @default.
• W2601256495 hasConcept C2778961205 @default.
• W2601256495 hasConcept C2780026642 @default.
• W2601256495 hasConcept C2780035454 @default.
• W2601256495 hasConcept C2780306776 @default.
• W2601256495 hasConcept C2780724011 @default.
• W2601256495 hasConcept C2781063702 @default.
• W2601256495 hasConcept C2781072394 @default.
• W2601256495 hasConcept C2987404301 @default.
• W2601256495 hasConcept C42219234 @default.
• W2601256495 hasConcept C71924100 @default.
• W2601256495 hasConcept C98274493 @default.
• W2601256495 hasConceptScore W2601256495C118552586 @default.
• W2601256495 hasConceptScore W2601256495C126322002 @default.
• W2601256495 hasConceptScore W2601256495C139719470 @default.
• W2601256495 hasConceptScore W2601256495C162324750 @default.
• W2601256495 hasConceptScore W2601256495C170493617 @default.
• W2601256495 hasConceptScore W2601256495C177713679 @default.
• W2601256495 hasConceptScore W2601256495C194828623 @default.
• W2601256495 hasConceptScore W2601256495C2776867660 @default.
• W2601256495 hasConceptScore W2601256495C2778750930 @default.
• W2601256495 hasConceptScore W2601256495C2778961205 @default.
• W2601256495 hasConceptScore W2601256495C2780026642 @default.
• W2601256495 hasConceptScore W2601256495C2780035454 @default.
• W2601256495 hasConceptScore W2601256495C2780306776 @default.
• W2601256495 hasConceptScore W2601256495C2780724011 @default.
• W2601256495 hasConceptScore W2601256495C2781063702 @default.
• W2601256495 hasConceptScore W2601256495C2781072394 @default.
• W2601256495 hasConceptScore W2601256495C2987404301 @default.
• W2601256495 hasConceptScore W2601256495C42219234 @default.
• W2601256495 hasConceptScore W2601256495C71924100 @default.

• next